TY - JOUR
T1 - The autism inpatient collection
T2 - Methods and preliminary sample description
AU - Siegel, Matthew
AU - Smith, Kahsi A.
AU - Mazefsky, Carla
AU - Gabriels, Robin L.
AU - Erickson, Craig
AU - Kaplan, Desmond
AU - Morrow, Eric M.
AU - Wink, Logan
AU - Santangelo, Susan L.
N1 - Funding Information:
The ADDIRC is made up of the co-investigators: Craig Erickson, M.D. (Cincinnati Children’s Hospital; University of Cincinnati); Robin L. Gabriels, PsyD (Children’s Hospital Colorado; University of Colorado), Desmond Kaplan, MD (Sheppard Pratt Health System), Carla Mazefsky, PhD (Western Psychiatric Institute and Clinics; University of Pittsburgh), Eric M. Morrow, MD, PhD (Bradley Hospital; Brown University), Susan L Santangelo, ScD (Maine Medical Center Research Institute; Tufts University), Matthew Siegel, MD (Maine Medical Center Research Institute; Tufts University), and Logan Wink, MD (Cincinnati Children’s Hospital; University of Cincinnati); and Carol Beresford, MD, Remy Chappell, LCPC, Edyta Chrzanowska, BA, Alicia Corbo, MA, Bridget Crippen, BS, Briar DeChant, BA, Tom Flis, BCBA, LCPC, Holly Gastgeb, PhD, Angela Geer, BA, Louis Hagopian, PhD, Benjamin Handen, PhD, BCBA-D, Beth Jerskey, PhD, Martin Lubetsky, MD, Kristen MacKenzie, BA, Zenoa Meservy, MD, John McGonigle, PhD, Ernest Pedapati, MD, Christine Peura, BA, Joseph Pierri, MD, Rebecca Schaffer, PhD, Cathleen Small, PhD, Kahsi Smith, PhD, Nicole Stuckey, MSN, RN, Barbara Tylenda, PhD, Mary Verdi, MA, Rick Wallace, MSN, RN, Deanna Williams, BA, and Diane Williams, PhD, CCC-SLP. We gratefully acknowledge the contributions of our coordinating site advisory group: Donald L. St. Germain, MD, and Girard Robinson, MD, and our scientific advisory group: Connie Kasari, PhD., Bryan King, MD, James McCracken, MD, Christopher McDougle, MD, Lawrence Scahill, MSN, PhD, Robert Schultz, PhD, and Helen Tager-Flusberg, PhD, the input of the funding organizations and the families and children who participated. The Autism Inpatient Collection (AIC) phenotypic database and biorepository is supported by a grant from the Simons Foundation Autism Research Initiative and the Nancy Lurie Marks Family Foundation, (SFARI #296318 to M.S.). The development of the EDI is supported by a grant from the National Institute of Child Health and Human Development (R01HD079512 to C.M.) and Dr. Mazefsky receives additional support from NICHD (K23HD060601). This work was also supported by a grant from the Simons Foundation (286756, EM) and Dr. Morrow is also supported by the National Institute of Mental Health (R01 MH105442).
Publisher Copyright:
© 2015 Siegel et al.
PY - 2015/11/10
Y1 - 2015/11/10
N2 - Background: Individuals severely affected by autism spectrum disorder (ASD), including those with intellectual disability, expressive language impairment, and/or self-injurious behavior (SIB), are underrepresented in the ASD literature and extant collections of phenotypic and biological data. An understanding of ASD's etiology and subtypes can only be as complete as the studied samples are representative. Methods: The Autism Inpatient Collection (AIC) is a multi-site study enrolling children and adolescents with ASD aged 4-20 years admitted to six specialized inpatient psychiatry units. Enrollment began March, 2014, and continues at a rate of over 400 children annually. Measures characterizing adaptive and cognitive functioning, communication, externalizing behaviors, emotion regulation, psychiatric co-morbidity, self-injurious behavior, parent stress, and parent self-efficacy are collected. ASD diagnosis is confirmed by the Autism Diagnostic Observation Schedule - 2 (ADOS-2) and extensive inpatient observation. Biological samples from probands and their biological parents are banked and processed for DNA extraction and creation of lymphoblastoid cell lines. Results: Sixty-one percent of eligible subjects were enrolled. The first 147 subjects were an average of 12.6 years old (SD 3.42, range 4-20); 26.5 % female; 74.8 % Caucasian, and 81.6 % non-Hispanic/non-Latino. Mean non-verbal intelligence quotient IQ = 70.9 (SD 29.16, range 30-137) and mean adaptive behavior composite score = 55.6 (SD 12.9, range 27-96). A majority of subjects (52.4 %) were non- or minimally verbal. The average Aberrant Behavior Checklist - Irritability Subscale score was 28.6, well above the typical threshold for clinically concerning externalizing behaviors, and 26.5 % of the sample engaged in SIB. Females had more frequent and severe SIB than males. Conclusions: Preliminary data indicate that the AIC has a rich representation of the portion of the autism spectrum that is understudied and underrepresented in extant data collections. More than half of the sample is non- or minimally verbal, over 40 % have intellectual disability, and over one quarter exhibit SIB. The AIC is a substantial new resource for study of the full autism spectrum, which will augment existing data on higher-functioning cohorts and facilitate the identification of genetic subtypes and novel treatment targets. The AIC investigators welcome collaborations with other investigators, and access to the AIC phenotypic data and biosamples may be requested through the Simons Foundation (www.sfari.org).
AB - Background: Individuals severely affected by autism spectrum disorder (ASD), including those with intellectual disability, expressive language impairment, and/or self-injurious behavior (SIB), are underrepresented in the ASD literature and extant collections of phenotypic and biological data. An understanding of ASD's etiology and subtypes can only be as complete as the studied samples are representative. Methods: The Autism Inpatient Collection (AIC) is a multi-site study enrolling children and adolescents with ASD aged 4-20 years admitted to six specialized inpatient psychiatry units. Enrollment began March, 2014, and continues at a rate of over 400 children annually. Measures characterizing adaptive and cognitive functioning, communication, externalizing behaviors, emotion regulation, psychiatric co-morbidity, self-injurious behavior, parent stress, and parent self-efficacy are collected. ASD diagnosis is confirmed by the Autism Diagnostic Observation Schedule - 2 (ADOS-2) and extensive inpatient observation. Biological samples from probands and their biological parents are banked and processed for DNA extraction and creation of lymphoblastoid cell lines. Results: Sixty-one percent of eligible subjects were enrolled. The first 147 subjects were an average of 12.6 years old (SD 3.42, range 4-20); 26.5 % female; 74.8 % Caucasian, and 81.6 % non-Hispanic/non-Latino. Mean non-verbal intelligence quotient IQ = 70.9 (SD 29.16, range 30-137) and mean adaptive behavior composite score = 55.6 (SD 12.9, range 27-96). A majority of subjects (52.4 %) were non- or minimally verbal. The average Aberrant Behavior Checklist - Irritability Subscale score was 28.6, well above the typical threshold for clinically concerning externalizing behaviors, and 26.5 % of the sample engaged in SIB. Females had more frequent and severe SIB than males. Conclusions: Preliminary data indicate that the AIC has a rich representation of the portion of the autism spectrum that is understudied and underrepresented in extant data collections. More than half of the sample is non- or minimally verbal, over 40 % have intellectual disability, and over one quarter exhibit SIB. The AIC is a substantial new resource for study of the full autism spectrum, which will augment existing data on higher-functioning cohorts and facilitate the identification of genetic subtypes and novel treatment targets. The AIC investigators welcome collaborations with other investigators, and access to the AIC phenotypic data and biosamples may be requested through the Simons Foundation (www.sfari.org).
KW - Autism spectrum disorder
KW - Genetics
KW - Inpatient
KW - Intellectual disability
KW - New data resource
KW - Non-verbal
KW - Psychiatric
KW - Self-injury
KW - Severe autism
UR - http://www.scopus.com/inward/record.url?scp=84946550510&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946550510&partnerID=8YFLogxK
U2 - 10.1186/s13229-015-0054-8
DO - 10.1186/s13229-015-0054-8
M3 - Article
AN - SCOPUS:84946550510
SN - 2040-2392
VL - 6
JO - Molecular Autism
JF - Molecular Autism
IS - 1
M1 - 61
ER -